Global Liquid Biopsy Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Liquid Biopsy market size was valued at US$ 4720 million in 2025 and is forecast to a readjusted size of US$ 15888 million by 2032 with a CAGR of 18.8% during review period.
Liquid biopsy is a molecular diagnostic technology that detects tumor-related biomarkers in body fluids such as blood, urine, or cerebrospinal fluid to enable disease screening, diagnosis, treatment monitoring, and recurrence surveillance. Compared with conventional tissue biopsy, liquid biopsy offers significant advantages including minimal invasiveness, repeatable sampling, and the ability to perform real-time dynamic monitoring. The technology primarily analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and tumor-derived RNA using advanced analytical platforms such as next-generation sequencing and digital PCR. Liquid biopsy provides a more comprehensive view of tumor molecular characteristics and heterogeneity, making it an important tool in precision medicine. With continuous advancements in genomic technologies, bioinformatics, and the growing demand for early cancer detection, liquid biopsy is increasingly becoming a key component of modern oncology diagnostics and translational research.The average gross profit margin of this product is 65%.
The continuous evolution of precision medicine is transforming clinical practice from empirical treatment toward molecular classification and personalized therapy, creating significant opportunities for liquid biopsy technologies. Increasing demand for sensitive molecular diagnostics in cancer screening, targeted therapy, and immunotherapy has positioned liquid biopsy as a critical bridge between diagnostics and treatment decision-making. Meanwhile, the declining cost of sequencing technologies and improvements in bioinformatics capabilities are enhancing the accessibility and scalability of liquid biopsy applications. Global pharmaceutical companies and research institutions are also increasing investments in early cancer detection and companion diagnostics, further accelerating technological innovation and commercialization in this field.
Despite its strong potential, liquid biopsy still faces several technical and regulatory challenges in clinical adoption. The extremely low concentration of tumor-derived molecules in body fluids requires highly sensitive and specific detection technologies, placing stringent demands on experimental workflows, analytical platforms, and data interpretation. In addition, the lack of standardized methodologies across different testing platforms may affect result consistency and clinical interpretation. Regulatory requirements for molecular diagnostic products are also becoming more rigorous, and the need for extensive clinical validation can lengthen the approval and commercialization process, potentially slowing market penetration.
Downstream demand for liquid biopsy is gradually expanding from late-stage cancer monitoring to broader clinical applications. Early cancer screening, treatment response evaluation, minimal residual disease detection, and recurrence monitoring are becoming increasingly important application areas. As precision oncology strategies continue to evolve, clinicians are relying more on dynamic molecular testing to guide treatment decisions, strengthening the role of liquid biopsy in clinical workflows. In addition, biopharmaceutical companies are increasingly adopting liquid biopsy technologies as companion diagnostic tools and research instruments in drug development, making them valuable in clinical trials and real-world evidence studies.
The upstream segment of the liquid biopsy industry mainly includes nucleic acid extraction reagents, sample preservation and stabilization reagents, sequencing reagents, and high-sensitivity molecular detection consumables. These materials directly influence detection sensitivity, stability, and experimental reproducibility, making them fundamental to overall test performance. As molecular diagnostics technologies continue to evolve, reagent suppliers are developing more efficient nucleic acid enrichment solutions and high-stability reagents to meet the demands of ultra-low concentration biomarker detection. Continuous improvements in automated sample processing systems and high-performance sequencing platforms are also driving technological advancement and scalability across the entire industry chain.
This report is a detailed and comprehensive analysis for global Liquid Biopsy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Liquid Biopsy market size and forecasts, in consumption value ($ Million), 2021-2032
Global Liquid Biopsy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Liquid Biopsy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Liquid Biopsy market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Liquid Biopsy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Liquid Biopsy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Liquid Biopsy, with revenue, gross margin, and global market share of Liquid Biopsy from 2021 to 2026.
Chapter 3, the Liquid Biopsy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Liquid Biopsy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Liquid Biopsy.
Chapter 13, to describe Liquid Biopsy research findings and conclusion.
Liquid biopsy is a molecular diagnostic technology that detects tumor-related biomarkers in body fluids such as blood, urine, or cerebrospinal fluid to enable disease screening, diagnosis, treatment monitoring, and recurrence surveillance. Compared with conventional tissue biopsy, liquid biopsy offers significant advantages including minimal invasiveness, repeatable sampling, and the ability to perform real-time dynamic monitoring. The technology primarily analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and tumor-derived RNA using advanced analytical platforms such as next-generation sequencing and digital PCR. Liquid biopsy provides a more comprehensive view of tumor molecular characteristics and heterogeneity, making it an important tool in precision medicine. With continuous advancements in genomic technologies, bioinformatics, and the growing demand for early cancer detection, liquid biopsy is increasingly becoming a key component of modern oncology diagnostics and translational research.The average gross profit margin of this product is 65%.
The continuous evolution of precision medicine is transforming clinical practice from empirical treatment toward molecular classification and personalized therapy, creating significant opportunities for liquid biopsy technologies. Increasing demand for sensitive molecular diagnostics in cancer screening, targeted therapy, and immunotherapy has positioned liquid biopsy as a critical bridge between diagnostics and treatment decision-making. Meanwhile, the declining cost of sequencing technologies and improvements in bioinformatics capabilities are enhancing the accessibility and scalability of liquid biopsy applications. Global pharmaceutical companies and research institutions are also increasing investments in early cancer detection and companion diagnostics, further accelerating technological innovation and commercialization in this field.
Despite its strong potential, liquid biopsy still faces several technical and regulatory challenges in clinical adoption. The extremely low concentration of tumor-derived molecules in body fluids requires highly sensitive and specific detection technologies, placing stringent demands on experimental workflows, analytical platforms, and data interpretation. In addition, the lack of standardized methodologies across different testing platforms may affect result consistency and clinical interpretation. Regulatory requirements for molecular diagnostic products are also becoming more rigorous, and the need for extensive clinical validation can lengthen the approval and commercialization process, potentially slowing market penetration.
Downstream demand for liquid biopsy is gradually expanding from late-stage cancer monitoring to broader clinical applications. Early cancer screening, treatment response evaluation, minimal residual disease detection, and recurrence monitoring are becoming increasingly important application areas. As precision oncology strategies continue to evolve, clinicians are relying more on dynamic molecular testing to guide treatment decisions, strengthening the role of liquid biopsy in clinical workflows. In addition, biopharmaceutical companies are increasingly adopting liquid biopsy technologies as companion diagnostic tools and research instruments in drug development, making them valuable in clinical trials and real-world evidence studies.
The upstream segment of the liquid biopsy industry mainly includes nucleic acid extraction reagents, sample preservation and stabilization reagents, sequencing reagents, and high-sensitivity molecular detection consumables. These materials directly influence detection sensitivity, stability, and experimental reproducibility, making them fundamental to overall test performance. As molecular diagnostics technologies continue to evolve, reagent suppliers are developing more efficient nucleic acid enrichment solutions and high-stability reagents to meet the demands of ultra-low concentration biomarker detection. Continuous improvements in automated sample processing systems and high-performance sequencing platforms are also driving technological advancement and scalability across the entire industry chain.
This report is a detailed and comprehensive analysis for global Liquid Biopsy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Liquid Biopsy market size and forecasts, in consumption value ($ Million), 2021-2032
Global Liquid Biopsy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Liquid Biopsy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Liquid Biopsy market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Liquid Biopsy
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Liquid Biopsy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- ctDNA Test
- CTC Test
- Exosome Test
- Cell-free RNA Test
- Other
- NGS Sequencing
- Digital PCR
- Real-time PCR
- Other
- Blood Sample
- Urine Sample
- Other
- Hospitals Labs
- Reference Labs
- Other
- Guardant Health
- Grail
- Natera
- Roche
- Roche Diagnostics
- Qiagen
- Bio-Rad
- Thermo Fisher Scientific
- Exact Sciences
- Illumina
- Burning Rock Biotech
- Novogen
- Berry Oncology
- BGI
- MDxHealth
- NeoGenomics Laboraories
- Myriad Genetics
- Aide Bio
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Liquid Biopsy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Liquid Biopsy, with revenue, gross margin, and global market share of Liquid Biopsy from 2021 to 2026.
Chapter 3, the Liquid Biopsy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Liquid Biopsy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Liquid Biopsy.
Chapter 13, to describe Liquid Biopsy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Liquid Biopsy by Type
1.3.1 Overview: Global Liquid Biopsy Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Liquid Biopsy Consumption Value Market Share by Type in 2025
1.3.3 ctDNA Test
1.3.4 CTC Test
1.3.5 Exosome Test
1.3.6 Cell-free RNA Test
1.3.7 Other
1.4 Classification of Liquid Biopsy by Technology Platform
1.4.1 Overview: Global Liquid Biopsy Market Size by Technology Platform: 2021 Versus 2025 Versus 2032
1.4.2 Global Liquid Biopsy Consumption Value Market Share by Technology Platform in 2025
1.4.3 NGS Sequencing
1.4.4 Digital PCR
1.4.5 Real-time PCR
1.4.6 Other
1.5 Classification of Liquid Biopsy by Sample
1.5.1 Overview: Global Liquid Biopsy Market Size by Sample: 2021 Versus 2025 Versus 2032
1.5.2 Global Liquid Biopsy Consumption Value Market Share by Sample in 2025
1.5.3 Blood Sample
1.5.4 Urine Sample
1.5.5 Other
1.6 Global Liquid Biopsy Market by Application
1.6.1 Overview: Global Liquid Biopsy Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals Labs
1.6.3 Reference Labs
1.6.4 Other
1.7 Global Liquid Biopsy Market Size & Forecast
1.8 Global Liquid Biopsy Market Size and Forecast by Region
1.8.1 Global Liquid Biopsy Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Liquid Biopsy Market Size by Region, (2021-2032)
1.8.3 North America Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.4 Europe Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.6 South America Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Liquid Biopsy Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Guardant Health
2.1.1 Guardant Health Details
2.1.2 Guardant Health Major Business
2.1.3 Guardant Health Liquid Biopsy Product and Solutions
2.1.4 Guardant Health Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Guardant Health Recent Developments and Future Plans
2.2 Grail
2.2.1 Grail Details
2.2.2 Grail Major Business
2.2.3 Grail Liquid Biopsy Product and Solutions
2.2.4 Grail Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Grail Recent Developments and Future Plans
2.3 Natera
2.3.1 Natera Details
2.3.2 Natera Major Business
2.3.3 Natera Liquid Biopsy Product and Solutions
2.3.4 Natera Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Natera Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Liquid Biopsy Product and Solutions
2.4.4 Roche Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Roche Recent Developments and Future Plans
2.5 Roche Diagnostics
2.5.1 Roche Diagnostics Details
2.5.2 Roche Diagnostics Major Business
2.5.3 Roche Diagnostics Liquid Biopsy Product and Solutions
2.5.4 Roche Diagnostics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Roche Diagnostics Recent Developments and Future Plans
2.6 Qiagen
2.6.1 Qiagen Details
2.6.2 Qiagen Major Business
2.6.3 Qiagen Liquid Biopsy Product and Solutions
2.6.4 Qiagen Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Qiagen Recent Developments and Future Plans
2.7 Bio-Rad
2.7.1 Bio-Rad Details
2.7.2 Bio-Rad Major Business
2.7.3 Bio-Rad Liquid Biopsy Product and Solutions
2.7.4 Bio-Rad Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Bio-Rad Recent Developments and Future Plans
2.8 Thermo Fisher Scientific
2.8.1 Thermo Fisher Scientific Details
2.8.2 Thermo Fisher Scientific Major Business
2.8.3 Thermo Fisher Scientific Liquid Biopsy Product and Solutions
2.8.4 Thermo Fisher Scientific Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.9 Exact Sciences
2.9.1 Exact Sciences Details
2.9.2 Exact Sciences Major Business
2.9.3 Exact Sciences Liquid Biopsy Product and Solutions
2.9.4 Exact Sciences Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Exact Sciences Recent Developments and Future Plans
2.10 Illumina
2.10.1 Illumina Details
2.10.2 Illumina Major Business
2.10.3 Illumina Liquid Biopsy Product and Solutions
2.10.4 Illumina Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Illumina Recent Developments and Future Plans
2.11 Burning Rock Biotech
2.11.1 Burning Rock Biotech Details
2.11.2 Burning Rock Biotech Major Business
2.11.3 Burning Rock Biotech Liquid Biopsy Product and Solutions
2.11.4 Burning Rock Biotech Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Burning Rock Biotech Recent Developments and Future Plans
2.12 Novogen
2.12.1 Novogen Details
2.12.2 Novogen Major Business
2.12.3 Novogen Liquid Biopsy Product and Solutions
2.12.4 Novogen Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Novogen Recent Developments and Future Plans
2.13 Berry Oncology
2.13.1 Berry Oncology Details
2.13.2 Berry Oncology Major Business
2.13.3 Berry Oncology Liquid Biopsy Product and Solutions
2.13.4 Berry Oncology Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Berry Oncology Recent Developments and Future Plans
2.14 BGI
2.14.1 BGI Details
2.14.2 BGI Major Business
2.14.3 BGI Liquid Biopsy Product and Solutions
2.14.4 BGI Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 BGI Recent Developments and Future Plans
2.15 MDxHealth
2.15.1 MDxHealth Details
2.15.2 MDxHealth Major Business
2.15.3 MDxHealth Liquid Biopsy Product and Solutions
2.15.4 MDxHealth Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 MDxHealth Recent Developments and Future Plans
2.16 NeoGenomics Laboraories
2.16.1 NeoGenomics Laboraories Details
2.16.2 NeoGenomics Laboraories Major Business
2.16.3 NeoGenomics Laboraories Liquid Biopsy Product and Solutions
2.16.4 NeoGenomics Laboraories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 NeoGenomics Laboraories Recent Developments and Future Plans
2.17 Myriad Genetics
2.17.1 Myriad Genetics Details
2.17.2 Myriad Genetics Major Business
2.17.3 Myriad Genetics Liquid Biopsy Product and Solutions
2.17.4 Myriad Genetics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Myriad Genetics Recent Developments and Future Plans
2.18 Aide Bio
2.18.1 Aide Bio Details
2.18.2 Aide Bio Major Business
2.18.3 Aide Bio Liquid Biopsy Product and Solutions
2.18.4 Aide Bio Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Aide Bio Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Liquid Biopsy Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Liquid Biopsy by Company Revenue
3.2.2 Top 3 Liquid Biopsy Players Market Share in 2025
3.2.3 Top 6 Liquid Biopsy Players Market Share in 2025
3.3 Liquid Biopsy Market: Overall Company Footprint Analysis
3.3.1 Liquid Biopsy Market: Region Footprint
3.3.2 Liquid Biopsy Market: Company Product Type Footprint
3.3.3 Liquid Biopsy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Liquid Biopsy Consumption Value and Market Share by Type (2021-2026)
4.2 Global Liquid Biopsy Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Liquid Biopsy Consumption Value Market Share by Application (2021-2026)
5.2 Global Liquid Biopsy Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Liquid Biopsy Consumption Value by Type (2021-2032)
6.2 North America Liquid Biopsy Market Size by Application (2021-2032)
6.3 North America Liquid Biopsy Market Size by Country
6.3.1 North America Liquid Biopsy Consumption Value by Country (2021-2032)
6.3.2 United States Liquid Biopsy Market Size and Forecast (2021-2032)
6.3.3 Canada Liquid Biopsy Market Size and Forecast (2021-2032)
6.3.4 Mexico Liquid Biopsy Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Liquid Biopsy Consumption Value by Type (2021-2032)
7.2 Europe Liquid Biopsy Consumption Value by Application (2021-2032)
7.3 Europe Liquid Biopsy Market Size by Country
7.3.1 Europe Liquid Biopsy Consumption Value by Country (2021-2032)
7.3.2 Germany Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.3 France Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.5 Russia Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.6 Italy Liquid Biopsy Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Liquid Biopsy Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Liquid Biopsy Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Liquid Biopsy Market Size by Region
8.3.1 Asia-Pacific Liquid Biopsy Consumption Value by Region (2021-2032)
8.3.2 China Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.3 Japan Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.4 South Korea Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.5 India Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.7 Australia Liquid Biopsy Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Liquid Biopsy Consumption Value by Type (2021-2032)
9.2 South America Liquid Biopsy Consumption Value by Application (2021-2032)
9.3 South America Liquid Biopsy Market Size by Country
9.3.1 South America Liquid Biopsy Consumption Value by Country (2021-2032)
9.3.2 Brazil Liquid Biopsy Market Size and Forecast (2021-2032)
9.3.3 Argentina Liquid Biopsy Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Liquid Biopsy Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Liquid Biopsy Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Liquid Biopsy Market Size by Country
10.3.1 Middle East & Africa Liquid Biopsy Consumption Value by Country (2021-2032)
10.3.2 Turkey Liquid Biopsy Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Liquid Biopsy Market Size and Forecast (2021-2032)
10.3.4 UAE Liquid Biopsy Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Liquid Biopsy Market Drivers
11.2 Liquid Biopsy Market Restraints
11.3 Liquid Biopsy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Liquid Biopsy Industry Chain
12.2 Liquid Biopsy Upstream Analysis
12.3 Liquid Biopsy Midstream Analysis
12.4 Liquid Biopsy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Liquid Biopsy by Type
1.3.1 Overview: Global Liquid Biopsy Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Liquid Biopsy Consumption Value Market Share by Type in 2025
1.3.3 ctDNA Test
1.3.4 CTC Test
1.3.5 Exosome Test
1.3.6 Cell-free RNA Test
1.3.7 Other
1.4 Classification of Liquid Biopsy by Technology Platform
1.4.1 Overview: Global Liquid Biopsy Market Size by Technology Platform: 2021 Versus 2025 Versus 2032
1.4.2 Global Liquid Biopsy Consumption Value Market Share by Technology Platform in 2025
1.4.3 NGS Sequencing
1.4.4 Digital PCR
1.4.5 Real-time PCR
1.4.6 Other
1.5 Classification of Liquid Biopsy by Sample
1.5.1 Overview: Global Liquid Biopsy Market Size by Sample: 2021 Versus 2025 Versus 2032
1.5.2 Global Liquid Biopsy Consumption Value Market Share by Sample in 2025
1.5.3 Blood Sample
1.5.4 Urine Sample
1.5.5 Other
1.6 Global Liquid Biopsy Market by Application
1.6.1 Overview: Global Liquid Biopsy Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals Labs
1.6.3 Reference Labs
1.6.4 Other
1.7 Global Liquid Biopsy Market Size & Forecast
1.8 Global Liquid Biopsy Market Size and Forecast by Region
1.8.1 Global Liquid Biopsy Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Liquid Biopsy Market Size by Region, (2021-2032)
1.8.3 North America Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.4 Europe Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.6 South America Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Liquid Biopsy Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Guardant Health
2.1.1 Guardant Health Details
2.1.2 Guardant Health Major Business
2.1.3 Guardant Health Liquid Biopsy Product and Solutions
2.1.4 Guardant Health Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Guardant Health Recent Developments and Future Plans
2.2 Grail
2.2.1 Grail Details
2.2.2 Grail Major Business
2.2.3 Grail Liquid Biopsy Product and Solutions
2.2.4 Grail Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Grail Recent Developments and Future Plans
2.3 Natera
2.3.1 Natera Details
2.3.2 Natera Major Business
2.3.3 Natera Liquid Biopsy Product and Solutions
2.3.4 Natera Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Natera Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Liquid Biopsy Product and Solutions
2.4.4 Roche Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Roche Recent Developments and Future Plans
2.5 Roche Diagnostics
2.5.1 Roche Diagnostics Details
2.5.2 Roche Diagnostics Major Business
2.5.3 Roche Diagnostics Liquid Biopsy Product and Solutions
2.5.4 Roche Diagnostics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Roche Diagnostics Recent Developments and Future Plans
2.6 Qiagen
2.6.1 Qiagen Details
2.6.2 Qiagen Major Business
2.6.3 Qiagen Liquid Biopsy Product and Solutions
2.6.4 Qiagen Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Qiagen Recent Developments and Future Plans
2.7 Bio-Rad
2.7.1 Bio-Rad Details
2.7.2 Bio-Rad Major Business
2.7.3 Bio-Rad Liquid Biopsy Product and Solutions
2.7.4 Bio-Rad Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Bio-Rad Recent Developments and Future Plans
2.8 Thermo Fisher Scientific
2.8.1 Thermo Fisher Scientific Details
2.8.2 Thermo Fisher Scientific Major Business
2.8.3 Thermo Fisher Scientific Liquid Biopsy Product and Solutions
2.8.4 Thermo Fisher Scientific Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.9 Exact Sciences
2.9.1 Exact Sciences Details
2.9.2 Exact Sciences Major Business
2.9.3 Exact Sciences Liquid Biopsy Product and Solutions
2.9.4 Exact Sciences Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Exact Sciences Recent Developments and Future Plans
2.10 Illumina
2.10.1 Illumina Details
2.10.2 Illumina Major Business
2.10.3 Illumina Liquid Biopsy Product and Solutions
2.10.4 Illumina Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Illumina Recent Developments and Future Plans
2.11 Burning Rock Biotech
2.11.1 Burning Rock Biotech Details
2.11.2 Burning Rock Biotech Major Business
2.11.3 Burning Rock Biotech Liquid Biopsy Product and Solutions
2.11.4 Burning Rock Biotech Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Burning Rock Biotech Recent Developments and Future Plans
2.12 Novogen
2.12.1 Novogen Details
2.12.2 Novogen Major Business
2.12.3 Novogen Liquid Biopsy Product and Solutions
2.12.4 Novogen Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Novogen Recent Developments and Future Plans
2.13 Berry Oncology
2.13.1 Berry Oncology Details
2.13.2 Berry Oncology Major Business
2.13.3 Berry Oncology Liquid Biopsy Product and Solutions
2.13.4 Berry Oncology Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Berry Oncology Recent Developments and Future Plans
2.14 BGI
2.14.1 BGI Details
2.14.2 BGI Major Business
2.14.3 BGI Liquid Biopsy Product and Solutions
2.14.4 BGI Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 BGI Recent Developments and Future Plans
2.15 MDxHealth
2.15.1 MDxHealth Details
2.15.2 MDxHealth Major Business
2.15.3 MDxHealth Liquid Biopsy Product and Solutions
2.15.4 MDxHealth Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 MDxHealth Recent Developments and Future Plans
2.16 NeoGenomics Laboraories
2.16.1 NeoGenomics Laboraories Details
2.16.2 NeoGenomics Laboraories Major Business
2.16.3 NeoGenomics Laboraories Liquid Biopsy Product and Solutions
2.16.4 NeoGenomics Laboraories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 NeoGenomics Laboraories Recent Developments and Future Plans
2.17 Myriad Genetics
2.17.1 Myriad Genetics Details
2.17.2 Myriad Genetics Major Business
2.17.3 Myriad Genetics Liquid Biopsy Product and Solutions
2.17.4 Myriad Genetics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Myriad Genetics Recent Developments and Future Plans
2.18 Aide Bio
2.18.1 Aide Bio Details
2.18.2 Aide Bio Major Business
2.18.3 Aide Bio Liquid Biopsy Product and Solutions
2.18.4 Aide Bio Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Aide Bio Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Liquid Biopsy Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Liquid Biopsy by Company Revenue
3.2.2 Top 3 Liquid Biopsy Players Market Share in 2025
3.2.3 Top 6 Liquid Biopsy Players Market Share in 2025
3.3 Liquid Biopsy Market: Overall Company Footprint Analysis
3.3.1 Liquid Biopsy Market: Region Footprint
3.3.2 Liquid Biopsy Market: Company Product Type Footprint
3.3.3 Liquid Biopsy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Liquid Biopsy Consumption Value and Market Share by Type (2021-2026)
4.2 Global Liquid Biopsy Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Liquid Biopsy Consumption Value Market Share by Application (2021-2026)
5.2 Global Liquid Biopsy Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Liquid Biopsy Consumption Value by Type (2021-2032)
6.2 North America Liquid Biopsy Market Size by Application (2021-2032)
6.3 North America Liquid Biopsy Market Size by Country
6.3.1 North America Liquid Biopsy Consumption Value by Country (2021-2032)
6.3.2 United States Liquid Biopsy Market Size and Forecast (2021-2032)
6.3.3 Canada Liquid Biopsy Market Size and Forecast (2021-2032)
6.3.4 Mexico Liquid Biopsy Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Liquid Biopsy Consumption Value by Type (2021-2032)
7.2 Europe Liquid Biopsy Consumption Value by Application (2021-2032)
7.3 Europe Liquid Biopsy Market Size by Country
7.3.1 Europe Liquid Biopsy Consumption Value by Country (2021-2032)
7.3.2 Germany Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.3 France Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.5 Russia Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.6 Italy Liquid Biopsy Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Liquid Biopsy Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Liquid Biopsy Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Liquid Biopsy Market Size by Region
8.3.1 Asia-Pacific Liquid Biopsy Consumption Value by Region (2021-2032)
8.3.2 China Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.3 Japan Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.4 South Korea Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.5 India Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.7 Australia Liquid Biopsy Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Liquid Biopsy Consumption Value by Type (2021-2032)
9.2 South America Liquid Biopsy Consumption Value by Application (2021-2032)
9.3 South America Liquid Biopsy Market Size by Country
9.3.1 South America Liquid Biopsy Consumption Value by Country (2021-2032)
9.3.2 Brazil Liquid Biopsy Market Size and Forecast (2021-2032)
9.3.3 Argentina Liquid Biopsy Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Liquid Biopsy Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Liquid Biopsy Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Liquid Biopsy Market Size by Country
10.3.1 Middle East & Africa Liquid Biopsy Consumption Value by Country (2021-2032)
10.3.2 Turkey Liquid Biopsy Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Liquid Biopsy Market Size and Forecast (2021-2032)
10.3.4 UAE Liquid Biopsy Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Liquid Biopsy Market Drivers
11.2 Liquid Biopsy Market Restraints
11.3 Liquid Biopsy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Liquid Biopsy Industry Chain
12.2 Liquid Biopsy Upstream Analysis
12.3 Liquid Biopsy Midstream Analysis
12.4 Liquid Biopsy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Liquid Biopsy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Liquid Biopsy Consumption Value by Technology Platform, (USD Million), 2021 & 2025 & 2032
Table 3. Global Liquid Biopsy Consumption Value by Sample, (USD Million), 2021 & 2025 & 2032
Table 4. Global Liquid Biopsy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Liquid Biopsy Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Liquid Biopsy Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Guardant Health Company Information, Head Office, and Major Competitors
Table 8. Guardant Health Major Business
Table 9. Guardant Health Liquid Biopsy Product and Solutions
Table 10. Guardant Health Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Guardant Health Recent Developments and Future Plans
Table 12. Grail Company Information, Head Office, and Major Competitors
Table 13. Grail Major Business
Table 14. Grail Liquid Biopsy Product and Solutions
Table 15. Grail Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Grail Recent Developments and Future Plans
Table 17. Natera Company Information, Head Office, and Major Competitors
Table 18. Natera Major Business
Table 19. Natera Liquid Biopsy Product and Solutions
Table 20. Natera Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Roche Company Information, Head Office, and Major Competitors
Table 22. Roche Major Business
Table 23. Roche Liquid Biopsy Product and Solutions
Table 24. Roche Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Roche Recent Developments and Future Plans
Table 26. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 27. Roche Diagnostics Major Business
Table 28. Roche Diagnostics Liquid Biopsy Product and Solutions
Table 29. Roche Diagnostics Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Roche Diagnostics Recent Developments and Future Plans
Table 31. Qiagen Company Information, Head Office, and Major Competitors
Table 32. Qiagen Major Business
Table 33. Qiagen Liquid Biopsy Product and Solutions
Table 34. Qiagen Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Qiagen Recent Developments and Future Plans
Table 36. Bio-Rad Company Information, Head Office, and Major Competitors
Table 37. Bio-Rad Major Business
Table 38. Bio-Rad Liquid Biopsy Product and Solutions
Table 39. Bio-Rad Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Bio-Rad Recent Developments and Future Plans
Table 41. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Liquid Biopsy Product and Solutions
Table 44. Thermo Fisher Scientific Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Thermo Fisher Scientific Recent Developments and Future Plans
Table 46. Exact Sciences Company Information, Head Office, and Major Competitors
Table 47. Exact Sciences Major Business
Table 48. Exact Sciences Liquid Biopsy Product and Solutions
Table 49. Exact Sciences Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Exact Sciences Recent Developments and Future Plans
Table 51. Illumina Company Information, Head Office, and Major Competitors
Table 52. Illumina Major Business
Table 53. Illumina Liquid Biopsy Product and Solutions
Table 54. Illumina Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Illumina Recent Developments and Future Plans
Table 56. Burning Rock Biotech Company Information, Head Office, and Major Competitors
Table 57. Burning Rock Biotech Major Business
Table 58. Burning Rock Biotech Liquid Biopsy Product and Solutions
Table 59. Burning Rock Biotech Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Burning Rock Biotech Recent Developments and Future Plans
Table 61. Novogen Company Information, Head Office, and Major Competitors
Table 62. Novogen Major Business
Table 63. Novogen Liquid Biopsy Product and Solutions
Table 64. Novogen Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Novogen Recent Developments and Future Plans
Table 66. Berry Oncology Company Information, Head Office, and Major Competitors
Table 67. Berry Oncology Major Business
Table 68. Berry Oncology Liquid Biopsy Product and Solutions
Table 69. Berry Oncology Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Berry Oncology Recent Developments and Future Plans
Table 71. BGI Company Information, Head Office, and Major Competitors
Table 72. BGI Major Business
Table 73. BGI Liquid Biopsy Product and Solutions
Table 74. BGI Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. BGI Recent Developments and Future Plans
Table 76. MDxHealth Company Information, Head Office, and Major Competitors
Table 77. MDxHealth Major Business
Table 78. MDxHealth Liquid Biopsy Product and Solutions
Table 79. MDxHealth Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. MDxHealth Recent Developments and Future Plans
Table 81. NeoGenomics Laboraories Company Information, Head Office, and Major Competitors
Table 82. NeoGenomics Laboraories Major Business
Table 83. NeoGenomics Laboraories Liquid Biopsy Product and Solutions
Table 84. NeoGenomics Laboraories Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. NeoGenomics Laboraories Recent Developments and Future Plans
Table 86. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 87. Myriad Genetics Major Business
Table 88. Myriad Genetics Liquid Biopsy Product and Solutions
Table 89. Myriad Genetics Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Myriad Genetics Recent Developments and Future Plans
Table 91. Aide Bio Company Information, Head Office, and Major Competitors
Table 92. Aide Bio Major Business
Table 93. Aide Bio Liquid Biopsy Product and Solutions
Table 94. Aide Bio Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Aide Bio Recent Developments and Future Plans
Table 96. Global Liquid Biopsy Revenue (USD Million) by Players (2021-2026)
Table 97. Global Liquid Biopsy Revenue Share by Players (2021-2026)
Table 98. Breakdown of Liquid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 99. Market Position of Players in Liquid Biopsy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 100. Head Office of Key Liquid Biopsy Players
Table 101. Liquid Biopsy Market: Company Product Type Footprint
Table 102. Liquid Biopsy Market: Company Product Application Footprint
Table 103. Liquid Biopsy New Market Entrants and Barriers to Market Entry
Table 104. Liquid Biopsy Mergers, Acquisition, Agreements, and Collaborations
Table 105. Global Liquid Biopsy Consumption Value (USD Million) by Type (2021-2026)
Table 106. Global Liquid Biopsy Consumption Value Share by Type (2021-2026)
Table 107. Global Liquid Biopsy Consumption Value Forecast by Type (2027-2032)
Table 108. Global Liquid Biopsy Consumption Value by Application (2021-2026)
Table 109. Global Liquid Biopsy Consumption Value Forecast by Application (2027-2032)
Table 110. North America Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 111. North America Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 112. North America Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 113. North America Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 114. North America Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 115. North America Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 116. Europe Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 117. Europe Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 118. Europe Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 119. Europe Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 120. Europe Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 121. Europe Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 122. Asia-Pacific Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 123. Asia-Pacific Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 124. Asia-Pacific Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 125. Asia-Pacific Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 126. Asia-Pacific Liquid Biopsy Consumption Value by Region (2021-2026) & (USD Million)
Table 127. Asia-Pacific Liquid Biopsy Consumption Value by Region (2027-2032) & (USD Million)
Table 128. South America Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 129. South America Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 130. South America Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 131. South America Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 132. South America Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 133. South America Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 134. Middle East & Africa Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 135. Middle East & Africa Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 136. Middle East & Africa Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 137. Middle East & Africa Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 138. Middle East & Africa Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 139. Middle East & Africa Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 140. Global Key Players of Liquid Biopsy Upstream (Raw Materials)
Table 141. Global Liquid Biopsy Typical Customers
Table 1. Global Liquid Biopsy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Liquid Biopsy Consumption Value by Technology Platform, (USD Million), 2021 & 2025 & 2032
Table 3. Global Liquid Biopsy Consumption Value by Sample, (USD Million), 2021 & 2025 & 2032
Table 4. Global Liquid Biopsy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Liquid Biopsy Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Liquid Biopsy Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Guardant Health Company Information, Head Office, and Major Competitors
Table 8. Guardant Health Major Business
Table 9. Guardant Health Liquid Biopsy Product and Solutions
Table 10. Guardant Health Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Guardant Health Recent Developments and Future Plans
Table 12. Grail Company Information, Head Office, and Major Competitors
Table 13. Grail Major Business
Table 14. Grail Liquid Biopsy Product and Solutions
Table 15. Grail Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Grail Recent Developments and Future Plans
Table 17. Natera Company Information, Head Office, and Major Competitors
Table 18. Natera Major Business
Table 19. Natera Liquid Biopsy Product and Solutions
Table 20. Natera Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Roche Company Information, Head Office, and Major Competitors
Table 22. Roche Major Business
Table 23. Roche Liquid Biopsy Product and Solutions
Table 24. Roche Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Roche Recent Developments and Future Plans
Table 26. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 27. Roche Diagnostics Major Business
Table 28. Roche Diagnostics Liquid Biopsy Product and Solutions
Table 29. Roche Diagnostics Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Roche Diagnostics Recent Developments and Future Plans
Table 31. Qiagen Company Information, Head Office, and Major Competitors
Table 32. Qiagen Major Business
Table 33. Qiagen Liquid Biopsy Product and Solutions
Table 34. Qiagen Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Qiagen Recent Developments and Future Plans
Table 36. Bio-Rad Company Information, Head Office, and Major Competitors
Table 37. Bio-Rad Major Business
Table 38. Bio-Rad Liquid Biopsy Product and Solutions
Table 39. Bio-Rad Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Bio-Rad Recent Developments and Future Plans
Table 41. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Liquid Biopsy Product and Solutions
Table 44. Thermo Fisher Scientific Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Thermo Fisher Scientific Recent Developments and Future Plans
Table 46. Exact Sciences Company Information, Head Office, and Major Competitors
Table 47. Exact Sciences Major Business
Table 48. Exact Sciences Liquid Biopsy Product and Solutions
Table 49. Exact Sciences Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Exact Sciences Recent Developments and Future Plans
Table 51. Illumina Company Information, Head Office, and Major Competitors
Table 52. Illumina Major Business
Table 53. Illumina Liquid Biopsy Product and Solutions
Table 54. Illumina Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Illumina Recent Developments and Future Plans
Table 56. Burning Rock Biotech Company Information, Head Office, and Major Competitors
Table 57. Burning Rock Biotech Major Business
Table 58. Burning Rock Biotech Liquid Biopsy Product and Solutions
Table 59. Burning Rock Biotech Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Burning Rock Biotech Recent Developments and Future Plans
Table 61. Novogen Company Information, Head Office, and Major Competitors
Table 62. Novogen Major Business
Table 63. Novogen Liquid Biopsy Product and Solutions
Table 64. Novogen Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Novogen Recent Developments and Future Plans
Table 66. Berry Oncology Company Information, Head Office, and Major Competitors
Table 67. Berry Oncology Major Business
Table 68. Berry Oncology Liquid Biopsy Product and Solutions
Table 69. Berry Oncology Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Berry Oncology Recent Developments and Future Plans
Table 71. BGI Company Information, Head Office, and Major Competitors
Table 72. BGI Major Business
Table 73. BGI Liquid Biopsy Product and Solutions
Table 74. BGI Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. BGI Recent Developments and Future Plans
Table 76. MDxHealth Company Information, Head Office, and Major Competitors
Table 77. MDxHealth Major Business
Table 78. MDxHealth Liquid Biopsy Product and Solutions
Table 79. MDxHealth Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. MDxHealth Recent Developments and Future Plans
Table 81. NeoGenomics Laboraories Company Information, Head Office, and Major Competitors
Table 82. NeoGenomics Laboraories Major Business
Table 83. NeoGenomics Laboraories Liquid Biopsy Product and Solutions
Table 84. NeoGenomics Laboraories Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. NeoGenomics Laboraories Recent Developments and Future Plans
Table 86. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 87. Myriad Genetics Major Business
Table 88. Myriad Genetics Liquid Biopsy Product and Solutions
Table 89. Myriad Genetics Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Myriad Genetics Recent Developments and Future Plans
Table 91. Aide Bio Company Information, Head Office, and Major Competitors
Table 92. Aide Bio Major Business
Table 93. Aide Bio Liquid Biopsy Product and Solutions
Table 94. Aide Bio Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Aide Bio Recent Developments and Future Plans
Table 96. Global Liquid Biopsy Revenue (USD Million) by Players (2021-2026)
Table 97. Global Liquid Biopsy Revenue Share by Players (2021-2026)
Table 98. Breakdown of Liquid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 99. Market Position of Players in Liquid Biopsy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 100. Head Office of Key Liquid Biopsy Players
Table 101. Liquid Biopsy Market: Company Product Type Footprint
Table 102. Liquid Biopsy Market: Company Product Application Footprint
Table 103. Liquid Biopsy New Market Entrants and Barriers to Market Entry
Table 104. Liquid Biopsy Mergers, Acquisition, Agreements, and Collaborations
Table 105. Global Liquid Biopsy Consumption Value (USD Million) by Type (2021-2026)
Table 106. Global Liquid Biopsy Consumption Value Share by Type (2021-2026)
Table 107. Global Liquid Biopsy Consumption Value Forecast by Type (2027-2032)
Table 108. Global Liquid Biopsy Consumption Value by Application (2021-2026)
Table 109. Global Liquid Biopsy Consumption Value Forecast by Application (2027-2032)
Table 110. North America Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 111. North America Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 112. North America Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 113. North America Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 114. North America Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 115. North America Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 116. Europe Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 117. Europe Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 118. Europe Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 119. Europe Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 120. Europe Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 121. Europe Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 122. Asia-Pacific Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 123. Asia-Pacific Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 124. Asia-Pacific Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 125. Asia-Pacific Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 126. Asia-Pacific Liquid Biopsy Consumption Value by Region (2021-2026) & (USD Million)
Table 127. Asia-Pacific Liquid Biopsy Consumption Value by Region (2027-2032) & (USD Million)
Table 128. South America Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 129. South America Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 130. South America Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 131. South America Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 132. South America Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 133. South America Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 134. Middle East & Africa Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 135. Middle East & Africa Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 136. Middle East & Africa Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 137. Middle East & Africa Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 138. Middle East & Africa Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 139. Middle East & Africa Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 140. Global Key Players of Liquid Biopsy Upstream (Raw Materials)
Table 141. Global Liquid Biopsy Typical Customers
LIST OF FIGURES
Figure 1. Liquid Biopsy Picture
Figure 2. Global Liquid Biopsy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Liquid Biopsy Consumption Value Market Share by Type in 2025
Figure 4. ctDNA Test
Figure 5. CTC Test
Figure 6. Exosome Test
Figure 7. Cell-free RNA Test
Figure 8. Other
Figure 9. Global Liquid Biopsy Consumption Value by Technology Platform, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Liquid Biopsy Consumption Value Market Share by Technology Platform in 2025
Figure 11. NGS Sequencing
Figure 12. Digital PCR
Figure 13. Real-time PCR
Figure 14. Other
Figure 15. Global Liquid Biopsy Consumption Value by Sample, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Liquid Biopsy Consumption Value Market Share by Sample in 2025
Figure 17. Blood Sample
Figure 18. Urine Sample
Figure 19. Other
Figure 20. Global Liquid Biopsy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 21. Liquid Biopsy Consumption Value Market Share by Application in 2025
Figure 22. Hospitals Labs Picture
Figure 23. Reference Labs Picture
Figure 24. Other Picture
Figure 25. Global Liquid Biopsy Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 26. Global Liquid Biopsy Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 27. Global Market Liquid Biopsy Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 28. Global Liquid Biopsy Consumption Value Market Share by Region (2021-2032)
Figure 29. Global Liquid Biopsy Consumption Value Market Share by Region in 2025
Figure 30. North America Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 31. Europe Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 32. Asia-Pacific Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 33. South America Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 34. Middle East & Africa Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 35. Company Three Recent Developments and Future Plans
Figure 36. Global Liquid Biopsy Revenue Share by Players in 2025
Figure 37. Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 38. Market Share of Liquid Biopsy by Player Revenue in 2025
Figure 39. Top 3 Liquid Biopsy Players Market Share in 2025
Figure 40. Top 6 Liquid Biopsy Players Market Share in 2025
Figure 41. Global Liquid Biopsy Consumption Value Share by Type (2021-2026)
Figure 42. Global Liquid Biopsy Market Share Forecast by Type (2027-2032)
Figure 43. Global Liquid Biopsy Consumption Value Share by Application (2021-2026)
Figure 44. Global Liquid Biopsy Market Share Forecast by Application (2027-2032)
Figure 45. North America Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 46. North America Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 47. North America Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 52. Europe Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 53. Europe Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 55. France Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Liquid Biopsy Consumption Value Market Share by Region (2021-2032)
Figure 62. China Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 65. India Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 68. South America Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 69. South America Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 70. South America Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 71. Brazil Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 72. Argentina Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 73. Middle East & Africa Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 74. Middle East & Africa Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 75. Middle East & Africa Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 77. Saudi Arabia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 78. UAE Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 79. Liquid Biopsy Market Drivers
Figure 80. Liquid Biopsy Market Restraints
Figure 81. Liquid Biopsy Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Liquid Biopsy Industrial Chain
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Liquid Biopsy Picture
Figure 2. Global Liquid Biopsy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Liquid Biopsy Consumption Value Market Share by Type in 2025
Figure 4. ctDNA Test
Figure 5. CTC Test
Figure 6. Exosome Test
Figure 7. Cell-free RNA Test
Figure 8. Other
Figure 9. Global Liquid Biopsy Consumption Value by Technology Platform, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Liquid Biopsy Consumption Value Market Share by Technology Platform in 2025
Figure 11. NGS Sequencing
Figure 12. Digital PCR
Figure 13. Real-time PCR
Figure 14. Other
Figure 15. Global Liquid Biopsy Consumption Value by Sample, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Liquid Biopsy Consumption Value Market Share by Sample in 2025
Figure 17. Blood Sample
Figure 18. Urine Sample
Figure 19. Other
Figure 20. Global Liquid Biopsy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 21. Liquid Biopsy Consumption Value Market Share by Application in 2025
Figure 22. Hospitals Labs Picture
Figure 23. Reference Labs Picture
Figure 24. Other Picture
Figure 25. Global Liquid Biopsy Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 26. Global Liquid Biopsy Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 27. Global Market Liquid Biopsy Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 28. Global Liquid Biopsy Consumption Value Market Share by Region (2021-2032)
Figure 29. Global Liquid Biopsy Consumption Value Market Share by Region in 2025
Figure 30. North America Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 31. Europe Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 32. Asia-Pacific Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 33. South America Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 34. Middle East & Africa Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 35. Company Three Recent Developments and Future Plans
Figure 36. Global Liquid Biopsy Revenue Share by Players in 2025
Figure 37. Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 38. Market Share of Liquid Biopsy by Player Revenue in 2025
Figure 39. Top 3 Liquid Biopsy Players Market Share in 2025
Figure 40. Top 6 Liquid Biopsy Players Market Share in 2025
Figure 41. Global Liquid Biopsy Consumption Value Share by Type (2021-2026)
Figure 42. Global Liquid Biopsy Market Share Forecast by Type (2027-2032)
Figure 43. Global Liquid Biopsy Consumption Value Share by Application (2021-2026)
Figure 44. Global Liquid Biopsy Market Share Forecast by Application (2027-2032)
Figure 45. North America Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 46. North America Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 47. North America Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 52. Europe Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 53. Europe Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 55. France Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Liquid Biopsy Consumption Value Market Share by Region (2021-2032)
Figure 62. China Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 65. India Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 68. South America Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 69. South America Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 70. South America Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 71. Brazil Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 72. Argentina Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 73. Middle East & Africa Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 74. Middle East & Africa Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 75. Middle East & Africa Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 77. Saudi Arabia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 78. UAE Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 79. Liquid Biopsy Market Drivers
Figure 80. Liquid Biopsy Market Restraints
Figure 81. Liquid Biopsy Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Liquid Biopsy Industrial Chain
Figure 84. Methodology
Figure 85. Research Process and Data Source
